Checkpoint Therapeutics, Inc. (CKPT)

Checkpoint Therapeutics Statistics

Total Valuation

CKPT has a market cap or net worth of $183.12 million. The enterprise value is $178.42 million.

Market Cap	183.12M
Enterprise Value	178.42M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CKPT has 48.83 million shares outstanding. The number of shares has increased by 104.42% in one year.

Current Share Class	48.13M
Shares Outstanding	48.83M
Shares Change (YoY)	+104.42%
Shares Change (QoQ)	+18.14%
Owned by Insiders (%)	12.43%
Owned by Institutions (%)	8.10%
Float	33.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	4.32
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3,796.15
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.29

Current Ratio	0.29
Quick Ratio	0.26
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-633.94%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$2,043
Profits Per Employee	-$2.02M
Employee Count	23
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +114.29% in the last 52 weeks. The beta is 1.31, so CKPT's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	+114.29%
50-Day Moving Average	3.56
200-Day Moving Average	2.43
Relative Strength Index (RSI)	50.90
Average Volume (20 Days)	2,384,992

Short Selling Information

The latest short interest is 6.57 million, so 13.46% of the outstanding shares have been sold short.

Short Interest	6.57M
Short Previous Month	6.03M
Short % of Shares Out	13.46%
Short % of Float	19.47%
Short Ratio (days to cover)	5.70

Income Statement

In the last 12 months, CKPT had revenue of $47,000 and -$46.47 million in losses. Loss per share was -$1.01.

Revenue	47,000
Gross Profit	-27.60M
Operating Income	-37.51M
Pretax Income	-52.32M
Net Income	-46.47M
EBITDA	n/a
EBIT	-37.51M
Loss Per Share	-$1.01

Balance Sheet

Cash & Cash Equivalents	4.70M
Total Debt	n/a
Net Cash	4.70M
Net Cash Per Share	$0.10
Equity (Book Value)	-12.59M
Book Value Per Share	-0.27
Working Capital	-12.59M

Cash Flow

Operating Cash Flow	-30.76M
Capital Expenditures	n/a
Free Cash Flow	-30.76M
FCF Per Share	-$0.63

Margins

Gross Margin	n/a
Operating Margin	-79,817.02%
Pretax Margin	-98,868.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CKPT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-104.42%
Shareholder Yield	-104.42%
Earnings Yield	-25.38%
FCF Yield	-16.80%

Analyst Forecast

The average price target for CKPT is $10.33, which is 175.47% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.33
Price Target Difference	175.47%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on December 6, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Dec 6, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

CKPT has an Altman Z-Score of -116.96 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-116.96
Piotroski F-Score	2